EE200200034A - Katalüütilised faktor VIII vastased alloantikehad - Google Patents

Katalüütilised faktor VIII vastased alloantikehad

Info

Publication number
EE200200034A
EE200200034A EEP200200034A EEP200200034A EE200200034A EE 200200034 A EE200200034 A EE 200200034A EE P200200034 A EEP200200034 A EE P200200034A EE P200200034 A EEP200200034 A EE P200200034A EE 200200034 A EE200200034 A EE 200200034A
Authority
EE
Estonia
Prior art keywords
antibodies
factor viii
catalytic anti
viii allo
allo
Prior art date
Application number
EEP200200034A
Other languages
English (en)
Estonian (et)
Inventor
Kaveri Srinivas
Lacroix-Desmazes S�bastien
Kazatchkine Michel
Original Assignee
Institut National De La Sante Et De La Recherche Medicale (Inserm)
Bayer Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National De La Sante Et De La Recherche Medicale (Inserm), Bayer Pharma filed Critical Institut National De La Sante Et De La Recherche Medicale (Inserm)
Publication of EE200200034A publication Critical patent/EE200200034A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EEP200200034A 1999-07-21 2000-07-18 Katalüütilised faktor VIII vastased alloantikehad EE200200034A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99401841A EP1074842A1 (en) 1999-07-21 1999-07-21 Catalytic anti-factor VIII allo-antibodies
PCT/EP2000/006870 WO2001007918A1 (en) 1999-07-21 2000-07-18 Catalytic anti-factor viii allo-antibodies

Publications (1)

Publication Number Publication Date
EE200200034A true EE200200034A (et) 2003-06-16

Family

ID=8242069

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200034A EE200200034A (et) 1999-07-21 2000-07-18 Katalüütilised faktor VIII vastased alloantikehad

Country Status (24)

Country Link
US (2) US7507540B1 (cs)
EP (2) EP1074842A1 (cs)
JP (2) JP2003505434A (cs)
KR (1) KR100788435B1 (cs)
CN (1) CN1229646C (cs)
AU (1) AU777615B2 (cs)
BR (1) BR0012613A (cs)
CA (1) CA2379818A1 (cs)
CZ (1) CZ2002248A3 (cs)
EE (1) EE200200034A (cs)
HK (1) HK1044372A1 (cs)
HU (1) HUP0201941A3 (cs)
IL (1) IL147700A0 (cs)
IS (1) IS6238A (cs)
MX (1) MXPA02000752A (cs)
NO (1) NO20020253L (cs)
NZ (1) NZ516702A (cs)
PL (1) PL353739A1 (cs)
RU (1) RU2258935C2 (cs)
SK (1) SK862002A3 (cs)
TR (1) TR200200340T2 (cs)
UA (1) UA75867C2 (cs)
WO (1) WO2001007918A1 (cs)
ZA (1) ZA200200351B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2817964C (en) 2010-11-17 2018-06-12 Chugai Seiyaku Kabushiki Kaisha Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii
FR2969761A1 (fr) * 2010-12-22 2012-06-29 Lfb Biotechnologies Procede de dosage d'anticorps diriges contre le facteur viii
TWI700300B (zh) 2014-09-26 2020-08-01 日商中外製藥股份有限公司 中和具有第ｖｉｉｉ凝血因子（ｆｖｉｉｉ）機能替代活性的物質之抗體
TWI701435B (zh) * 2014-09-26 2020-08-11 日商中外製藥股份有限公司 測定ｆｖｉｉｉ的反應性之方法
MX2018012648A (es) 2016-04-28 2019-01-30 Chugai Pharmaceutical Co Ltd Preparaciones que contienen anticuerpos.
MX2020003472A (es) 2017-11-01 2020-08-03 Chugai Pharmaceutical Co Ltd Variante e isoforma de anticuerpos con actividad biologica reducida.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744446A (en) * 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
WO1994011013A1 (en) * 1992-11-13 1994-05-26 Duke University Chimeric blood coagulation proteins
US5910481A (en) * 1995-11-13 1999-06-08 Immuno Ag Hybrid proteins with modified activity
US5744326A (en) * 1996-03-11 1998-04-28 The Immune Response Corporation Use of viral CIS-acting post-transcriptional regulatory sequences to increase expression of intronless genes containing near-consensus splice sites

Also Published As

Publication number Publication date
EP1196782A1 (en) 2002-04-17
KR20020042618A (ko) 2002-06-05
HUP0201941A2 (en) 2002-10-28
MXPA02000752A (es) 2003-07-14
CZ2002248A3 (cs) 2002-07-17
IL147700A0 (en) 2002-08-14
HUP0201941A3 (en) 2005-01-28
RU2258935C2 (ru) 2005-08-20
JP2003505434A (ja) 2003-02-12
HK1044372A1 (zh) 2002-10-18
NO20020253L (no) 2002-03-13
IS6238A (is) 2002-01-16
BR0012613A (pt) 2002-04-09
TR200200340T2 (tr) 2003-01-21
CA2379818A1 (en) 2001-02-01
KR100788435B1 (ko) 2007-12-24
WO2001007918A1 (en) 2001-02-01
NZ516702A (en) 2003-10-31
NO20020253D0 (no) 2002-01-17
CN1361865A (zh) 2002-07-31
CN1229646C (zh) 2005-11-30
UA75867C2 (en) 2006-06-15
EP1074842A1 (en) 2001-02-07
SK862002A3 (en) 2002-06-04
JP2009292823A (ja) 2009-12-17
PL353739A1 (en) 2003-12-01
US20090208512A1 (en) 2009-08-20
ZA200200351B (en) 2003-03-26
US7507540B1 (en) 2009-03-24
AU777615B2 (en) 2004-10-21
AU6824500A (en) 2001-02-13

Similar Documents

Publication Publication Date Title
DE50008728D1 (de) Gassack
DE60037205D1 (de) Katalytische vorrichtungen
DE69909427D1 (de) Sicherheitsgurtaufroller
DE69931962T8 (de) Sicherheitsgurtaufroller
DE69917343D1 (de) Sicherheitsgurtaufroller
DK1308108T3 (da) Tandbörste
DE60009127D1 (de) Zahnbürste
NO20022615D0 (no) Koboltkatalysatorer
NO20003933L (no) Multikomponentkatalysatorer
NO20020120L (no) Stabile faktor VIII-sammensetninger
NO20004497L (no) Modifisert faktor VIII
DE10084428T1 (de) Zahnbürste
DE60002566D1 (de) Katalysatorsysteme
DE60025890D1 (de) Verbesserter Druckkopf
ID26688A (id) Katalis-katalis unggun tetap
DE50010729D1 (de) Gasgenerator
NO20003934D0 (no) Oksydkatalysatorer
DE60004363D1 (de) Faktor viia inhibitore
EE200200034A (et) Katalüütilised faktor VIII vastased alloantikehad
DE60010096D1 (de) Gurtaufroller
ATE259385T1 (de) Polymerisationskatalysatoren
ID26323A (id) Katalis untuk transesterifikasi
NO20023162L (no) Organometallkatalysator-preparater
DE69917884D1 (de) Sicherheitsgurtaufroller
ATE258184T1 (de) Oligomerisierungskatalysator